# EDGAR Filing Document

**Accession Number:** 0001533743
**File Stem:** 0002081456-25-000003
**Filing Date:** 2025-10
**Character Count:** 8558
**Document Hash:** 0156f6be3512d7fd54f99453905cf6b3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002081456-25-000003.hdr.sgml**: 20251015

**ACCESSION NUMBER**: 0002081456-25-000003

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251015

**DATE AS OF CHANGE**: 20251015

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Processa Pharmaceuticals, Inc.
- **CENTRAL INDEX KEY:** 0001533743
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 451539785
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-90420
- **FILM NUMBER:** 251394124

**BUSINESS ADDRESS:**
- **STREET 1:** 601 21ST STREET, SUITE 300
- **CITY:** VERO BEACH
- **STATE:** FL
- **ZIP:** 32960
- **BUSINESS PHONE:** 443-776-3133

**MAIL ADDRESS:**
- **STREET 1:** 601 21ST STREET, SUITE 300
- **CITY:** VERO BEACH
- **STATE:** FL
- **ZIP:** 32960

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Heatwurx, Inc.
- **DATE OF NAME CHANGE:** 20111028
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Chiliz Group Ltd.
- **CENTRAL INDEX KEY:** 0002081456

**ORGANIZATION NAME:**
- **EIN:** 998164932
- **STATE OF INCORPORATION:** O1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** LEVEL 6, WEMBLEY BUSINESS CENTRE
- **STREET 2:** 179, RUE D'ARGENS
- **CITY:** MSIDA
- **NON US STATE TERRITORY:** MSD
- **PROVINCE COUNTRY:** O1
- **ZIP:** 1360
- **BUSINESS PHONE:** 35699997878

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** LEVEL 6, WEMBLEY BUSINESS CENTRE
- **STREET 2:** 179, RUE D'ARGENS
- **CITY:** MSIDA
- **NON US STATE TERRITORY:** MSD
- **PROVINCE COUNTRY:** O1
- **ZIP:** 1360

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HX Entertainment Ltd
- **DATE OF NAME CHANGE:** 20250813

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 1)**

**Processa Pharmaceuticals, Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.0001 per share**

*(Title of Class of Securities)*

**74275C304**

*(CUSIP Number)*

**Michelle Reihel**<br>2029 Century Park East Suite 400<br>Los Angeles CA 90067<br>(213) 596-5620

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**08/05/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **74275C304** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Chiliz Group Ltd.** | Name of reporting person<br>**Chiliz Group Ltd.** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**O1** | Citizenship or place of organization<br>**O1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**5467181.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**5467181.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**5467181.00** | Aggregate amount beneficially owned by each reporting person<br>**5467181.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**10.9%** | Percent of class represented by amount in Row (11)<br>**10.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**CO** | Type of Reporting Person (See Instructions)<br>**CO** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.0001 per share

**(b) Name of Issuer:**
Processa Pharmaceuticals, Inc.

**(c) Address of Issuer's Principal Executive Offices:**
601 21ST STREET, SUITE 300, VERO BEACH, FL, 32960

**Item 4. Purpose of Transaction**

The Chiliz Group (formally, HX Entertainment) acquired the Common Stock for investment purposes as part of a strategic investment in the Issuer. The investment aligns with The Chiliz Groups's interest in companies exploring innovative financial strategies, particularly in the emerging biotech-fintech convergence sector.The Issuer has announced its exploration of cryptocurrency treasury strategies, which complements The Chiliz Group's expertise and investment focus in blockchain and digital asset technologies through its association with blockchain companies Chiliz and Socios.com.  The Chiliz Group currently intends to hold the Common Stock for investment purposes. However, The Chiliz Group continuously evaluates its investment in the Issuer and may, depending on various factors including but not limited to the Issuer's financial position, business strategy, market conditions, and other investment opportunities available to The Chiliz Group:(a) acquire additional securities of the Issuer or dispose of securities of the Issuer;(b) engage in discussions with management, the board of directors, and/or other stockholders of the Issuer regarding the business, operations, management, strategic alternatives, and future plans of the Issuer;(c) seek representation on the board of directors of the Issuer;(d) propose changes in the capitalization, ownership structure, board composition, or management of the Issuer;(e) propose strategic alternatives for the Issuer, including potential business combinations, mergers, or similar transactions;(f) propose changes to the Issuer's business strategy, including its announced cryptocurrency treasury initiatives; or(g) take any other actions which The Chiliz Group may determine to be necessary or desirable to maximize the value of its investment in the Issuer.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The Chiliz Group (formally, HX Entertainment) beneficially owns 5,467,181 shares of Common Stock, representing approximately 10.9% of the outstanding Common Stock of the Issuer based on 50,349,149 shares outstanding as of August 5, 2025, as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 7, 2025.  The Chiliz Group has sole voting power and sole dispositive power with respect to all 5,467,181 shares.

**(b)**
The Chiliz Group (formally, HX Entertainment) has sole voting power with respect to 5,467,181 shares and sole dispositive power with respect to 5,467,181 shares of Common Stock.

**(c)**
The following transactions in the Common Stock were effected by The Chiliz Group (formally, HX Entertainment) during the past sixty (60) days: Date: August 4, 2025Number of Shares: 5,032,398Price per Share: Approximately $0.2275Nature of Transaction: Purchase of restricted securities pursuant to Securities Purchase Agreement Date: August 5, 2025Number of Shares: 434,783Price per Share: Approximately $0.2275Nature of Transaction: Purchase of restricted securities pursuant to Securities Purchase Agreement  All shares were acquired pursuant to a Securities Purchase Agreement dated August 4, 2025, as disclosed in the Issuer's Form 8-K filed with the Securities and Exchange Commission on August 7, 2025.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

not applicable

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Chiliz Group Ltd.

**Signature:** Michelle Reihel

**Name/Title:** Michelle Reihel/Authorized signatory

**Date:** 10/15/2025